FDA Lists 22 Trials That Failed Phase III, Making the Case for the Gold Standard

The FDA compiled 22 case studies of different drugs, vaccines and devices that demonstrated promising results in Phase II studies, but later failed in larger Phase III clinical trials.
Source: Clinical Trials Advisor